China channel feed

Trail­ing No­var­tis and Eli Lil­ly, ra­dio­phar­ma­ceu­ti­cals start­up Full-Life Tech­nolo­gies nabs $63M to test new PS­MA drug

Last year
Financing
Manufacturing

Roche inks $50M ADC pact with Chi­nese biotech as field­'s flur­ry spills over in­to 2024

Last year
Deals
Pharma

As­traZeneca makes $1B deal for Gra­cell and its cell ther­a­pies, adding to Chi­na ties

Last year
Deals
Cell/Gene Tx

GSK se­cures an­oth­er ex-Chi­na ADC deal with Han­soh Phar­ma with $185M up­front

Last year
Deals

Ab­bisko signs $70M up­front deal with Mer­ck KGaA for PhI­II can­cer drug

Last year
Deals

Small transpa­cif­ic team led by Lil­ly, Ever­est vet turns to com­pu­ta­tion­al tools for next wave of pep­tide drug dis­cov­ery

Last year
Financing
Startups

BioN­Tech grabs PD-L1/VEGF bis­pe­cif­ic with $55M up­front, ex­pand­ing pipeline while low­er­ing Covid guid­ance

Last year
Deals

FDA green­lights first made-in-Chi­na PD-1 as Jun­shi, Co­herus beat BeiGene to the punch

Last year
FDA+

Dana­her’s third-quar­ter rev­enue from biotech ser­vices down 19% amid slow­down in Chi­na, US

Last year
Outsourcing
Pharma

Mer­ck ax­es two of nine AD­Cs in pact with Kelun-Biotech

Last year
Deals
Pharma

BioN­Tech sends $70M to an­oth­er ADC part­ner to go up against Dai­ichi Sankyo in HER3

Last year
Deals
Pharma

Sanofi adds an­oth­er AI al­liance, this time for bi­o­log­ics with Baidu CEO’s start­up

Last year
Deals
AI

Up­dat­ed: GSK taps Chi­nese part­ner to ramp up Shin­grix sales in $3.05B deal, with op­tion to ex­pand to RSV

Last year
Deals

Chi­nese cell ther­a­py biotech de­vel­op­ing TIL ther­a­pies rais­es $60M Se­ries B

Last year
Financing

AB­VC Bio­Phar­ma to break ground in Chi­na, ad­vances 20% stake in Zhonghui re­al es­tate 

Last year
R&D

In­no­force names De­wan Zeng as the new CEO

Last year
People
Manufacturing

Mer­ck KGaA, Mil­li­pore­Sig­ma make in­vest­ments in the US and Chi­na man­u­fac­tur­ing

Last year
Manufacturing

Up­dat­ed: FDA to im­port more of com­mon can­cer drug from Chi­na af­ter In­di­an site clo­sure

Last year
Pharma
Manufacturing

BeiGene fur­ther in­vests in AD­Cs with sol­id tu­mor part­ner Du­al­i­ty­Bio, a BioN­Tech col­lab­o­ra­tor

Last year
Startups
Deals

WuXi Bi­o­log­ics seeks spin­out, HK list­ing of bio­con­ju­gates-fo­cused joint ven­ture

Last year
Financing
Outsourcing

Chi­na ap­proves BC­MA CAR-T ther­a­py for mul­ti­ple myelo­ma, with In­novent beat­ing Leg­end in race to be first

Last year
Cell/Gene Tx

CSPC to launch Paxlovid ver­sion in Chi­na; SEC charges ex-Pfiz­er em­ploy­ee with in­sid­er trad­ing

Last year
Coronavirus
Law

Tout­ing pro­grams from No­var­tis, Laek­na bags $100M in Hong Kong IPO while Mer­ck-part­nered Kelun seeks up to $208M

Last year
Financing

As­traZeneca pon­ders a Chi­na phar­ma spin­off to pro­tect it­self from geopo­lit­i­cal fall­out — FT

Last year
Pharma
First page Previous page 6789101112 Next page Last page
A service from the Financial Times